REFRACTORY GRADE 3B FOLLICULAR LYMPHOMA
Clinical trials for REFRACTORY GRADE 3B FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY GRADE 3B FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for REFRACTORY GRADE 3B FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug may keep lymphoma in check before CAR-T treatment
Disease control Recruiting nowThis study tests a drug called odronextamab in people with large B-cell lymphomas that have returned or not responded to treatment. The drug is given before CAR-T cell therapy to control the cancer and help patients successfully receive the full treatment. About 27 adults will ta…
Matched conditions: REFRACTORY GRADE 3B FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
Promising new combo aims to shrink lymphoma before transplant
Disease control Recruiting nowThis study tests a two-step treatment for people with large B-cell lymphoma that has returned or not responded to initial therapy. First, patients receive a combination of tafasitamab (an antibody that targets cancer cells) and lenalidomide (a drug that helps the immune system fi…
Matched conditions: REFRACTORY GRADE 3B FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: David Bond, MD • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
Engineered immune cells take on HIV-Linked cancer in new trial
Disease control Recruiting nowThis phase 1 trial is testing a CAR-T cell therapy called axicabtagene ciloleucel in 20 adults with HIV and aggressive B-cell non-Hodgkin lymphoma that has come back or not responded to treatment. The therapy uses a patient's own immune cells, modified to recognize and attack can…
Matched conditions: REFRACTORY GRADE 3B FOLLICULAR LYMPHOMA
Phase: PHASE1 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC